Organisation paid for research Program year 2022 Source: CMS Open Payments

Allergy, Asthma & Sinus Center, S.C.

Neither a doctor nor a teaching hospital

Research payments

$127,943

25 payments

Through program year 2022, Allergy, Asthma & Sinus Center, S.C. is reported as receiving $127,943 in research payments, across 25 payments.

By program year

3 rows
Year Kind Amount Payments
2022 Research $10,520 1
2021 Research $43,153 4
2019 Research $74,270 20

Breakdown

Who paid Research payments · program years 2019–2022
  1. Sanofi US Services Inc. $61,502 14 payments
  2. Amphastar Pharmaceuticals, Inc. $49,682 3 payments
  3. Chiesi USA, Inc. $12,768 6 payments
  4. ALK-Abello, Inc $3,991 2 payments
Studies the money was for Research payments · program years 2019–2022
  1. A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O $27,352 7 payments
  2. Pilot Clinical Pharmacodynamic (PD) Bioequivalence (BE) Study of Ipratropium Bromide HFA MDI (A007) in Treatment for Chronic Obstructive Pulmonary Disease (COPD) $26,083 2 payments
  3. Pharmacodynamic (PD) Bronchodilatation Bioequivalence (BE) Study of Albuterol Sulfate HFA MDI 90 mcg/inhalation in Asthma Patients $23,599 1 payment
  4. A Randomized, Double-blind, Placebo-controlled, Parallel-group, 12-week Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety, and Tolerability of SAR440340 and the Coadministration of SAR440340 $23,234 5 payments
  5. Ccd-05993Aa3-01 $12,768 6 payments
  6. A Randomized, Double-blind, 52-week, Placebo Controlled Efficacy and Safety Study of Dupilumab, in Patients With Bilateral Nasal Polyposis on a Background Therapy With Intranasal Corticosteroids $5,967 1 payment
  7. A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe Chronic Obstructi $4,950 1 payment
  8. Mt-12 $3,991 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record